Home
Funding Areas
About Us
A Swiss biotech company says it has found a "game-changer" in the treatment of a rare and devastating genetic disorder affecting children.
The company, called Tx, is working on a device that would allow cells from a patient's own body to be injected into a patient's brain, reports the Globe and Mail.
The goal is to change the brain's ability to communicate with the outside world.
Currently, there is no approved treatment for the disorder, called Kodyukodystrophy, in which patients lose the ability to see, hear, or speak.
The device would allow cells from a patient's own immune system to be injected into the brain, where they would be able to communicate with the outside world.
It's believed to be the first time a gene therapy treatment has been developed to treat a disorder like Kodyukodystrophy, reports the New York Times, which describes the disease as a progressive loss of the brain's ability to communicate with the rest of the body.
Previously, the only treatment for the disorder was a bone marrow transplant.
Thomas Mehrling, the new CEO of Tx, has more than 25 years of biotech experience, including time at Mundipharma International, where he was in charge of the development of
Selected Grant News Headlines
A customized collection of grant news from foundations and the federal government from around the Web.
'Safety, compassion, innovation': Beaufort Memorial honors top staff at Bemmy Awards.The Quality Services department took home the award for Department of the Year at BeaufortMemorial Hospital's...more
This ranking recognizes the leading children's hospitals in the U.S., featuring the top 50 hospitals.Cleveland Clinic Children's placed in all eight pediatric subspecialities: Cardiology and Cardiac...more
Mackinac Policy Conference left early childhood education off this year's agenda.By 2027, make Detroit a city that puts young children and families first, says James Ribbron, executive director of...more
Investing in tech to help children and communities thrive | Takeda Stories.How our Global CSR Program helped empower diverse entrepreneurs to innovate health solutions.29 Digital public goods...more
Greg Bourke is the author of "Gay, Catholic, and American: My Legal Battle for Marriage Equality and Inclusion" Bourke spoke at the Yale School of Management's Social Impact Lab.Bourke's final advice...more
Tesla plans to deploy a small fleet of robotaxis in Austin in the coming weeks.Tesla FSD 13.2.9 will still run a kid down while illegally blowing past a stopped school bus with red lights flashing...more
Awarded funding will support a wide range of activities between now and September 30, 2025.The FCCN initiative, supported by $85,000 in grant funding, will help build and sustain a Family Child Care...more
The Delivering Innovative Vocational Education through Virtual Reality Technology new workforce training program aimed at preparing individuals with disabilities for the program.DIVE-VRT delivers...more
Children are growing up surrounded by screens, apps, and smart devices.Being intentional about tech use goes a long way toward deepening interest in tech and creating meaningful experiences.Creating...more
Safeguarding innovation and trade secrets in American AI leadership Safeguarded innovation andtrade secrets in U.S.AI leadership.Testimony was given before the House Judiciary Subcommittee on Courts,...more
Children News from...
Becton, Dickinson and Company
Johnson Foundation
Robert Wood Johnson Foundation
Social Entrepreneurship
Spotlight
When it Comes to Social Enterprises, Failure is the Best Platform for Innovation
In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.
